Marseille, France

Jean-Pierre Gorvel

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Universidad De Navarra. Active years: 2014-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Pierre Gorvel. Retrieved from https://idiyas.com/inventor/jean-pierre-gorvel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Marseilles Cedex, FR (2014)
  • Marseilles, FR (2015)
  • Marseille Cedex, FR (2015)

Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Jean-Pierre Gorvel

Introduction

Jean-Pierre Gorvel is a notable inventor based in Marseille, France. He has made significant contributions to the field of immunology through his innovative patents. With a total of three patents to his name, Gorvel's work focuses on enhancing vaccine efficacy and immune response.

Latest Patents

Gorvel's latest patents include "Immunoadjuvant compounds and uses thereof," which describes cyclic beta glucan compounds that function as immunoadjuvants. These compounds can be administered prior to, concurrently with, or after the administration of antigens to a subject. They are designed to activate dendritic cells, thereby enhancing the immune response. Another significant patent is for "Modified gram-negative bacteria for use as vaccines." This invention involves Gram-negative bacteria with an inactivated gene that alters the synthesis of lipopolysaccharides (LPS). These modified strains exhibit reduced virulence while still inducing sufficient humoral immunity for effective vaccination.

Career Highlights

Throughout his career, Gorvel has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His research has been pivotal in advancing vaccine technology and immunological research.

Collaborations

Gorvel has collaborated with notable colleagues, including Vilma Arce Gorvel and Maite Iriarte. Their joint efforts have contributed to the development of innovative solutions in the field of immunology.

Conclusion

Jean-Pierre Gorvel's contributions to immunology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence vaccine development and immune response enhancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…